Predictors of Outcome in Myasthenic Crisis

Area of Science:

• Neurology
• Immunology
• Critical Care Medicine

Background:

• Myasthenic crisis (MC) management requires careful consideration of immunosuppression strategies.
• The impact of maintenance steroid-sparing immunosuppression (SSIS) and prednisone dosage on MC outcomes, including sepsis development, is not well-defined.
• Understanding these factors is crucial for optimizing patient care during MC.

Purpose of the Study:

• To investigate the predictive value of maintenance SSIS and prednisone dosage on myasthenic crisis outcomes.
• To assess the influence of these variables on the development of sepsis in MC patients.

Main Methods:

• Retrospective, multi-center study analyzing data from 52 patients experiencing 57 MCs.
• Univariate and multivariate analyses were employed, including mixed-effect logistic regression and Cox proportional hazards regression.
• Key outcome measures included length of ICU stay and duration of ventilation.

Main Results:

• Sepsis was linked to longer ICU stays and ventilation durations (HR: 0.27-0.28).
• Predictors of sepsis included age >50 years (OR: 7.74) and high-dose prednisone (≥60mg/day) during ICU stay (OR: 13.07).
• Maintenance SSIS at MC onset predicted shorter ICU stays and ventilation durations (HR: 2.23-2.73).

Conclusions:

• Maintenance SSIS at MC onset is associated with improved clinical outcomes.
• Preventing sepsis and utilizing lower prednisone doses (<60mg/day) may mitigate risks and improve MC prognosis.
• These findings highlight the importance of tailored immunosuppressive strategies in managing myasthenic crisis.